Market Research Logo

Bipolar Disorder - Current and Future Players

Bipolar Disorder - Current and Future Players

Summary

GlobalData has released its pharma report, “Bipolar Disorder - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Bipolar Disorder Market. The report identifies and analyses the key companies shaping and driving the global Bipolar Disorder market. The report provides insight into the competitive Bipolar Disorder landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

  • Investigation of current and future market competition for Bipolar Disorder
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Bipolar Disorder sector through market impact analysis, future market scenario and company analysis
Reasons to buy
  • Gain a high level view of the trends shaping and driving Bipolar Disorder market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What’s the next big thing in the global Bipolar Disorder market landscape? Identify, understand and capitalize


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers - Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Otsuka
4.3.2 AstraZeneca
4.3.3 Eli Lilly
4.3.4 Allergan
4.3.5 Dainippon Sumitomo
4.3.6 Janssen
4.3.7 Lundbeck
4.3.8 Meiji Seika
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 Diagnosed Bipolar Disorder Patients
5.4.2 Percent Drug-Treated Patients
5.4.3 Launch and Patent Expiry Dates
5.4.4 General Pricing Assumptions
5.4.5 Individual Drug Assumptions
5.4.6 Generic Erosion
5.5 Primary Research - KOLs Interviewed for this Report
5.6 Primary Research - Prescriber Survey
5.7 About the Authors
5.7.1 Analyst
5.7.2 Therapy Area Director
5.7.3 Epidemiologist
5.7.4 Global Director of Therapy Research and Analysis
5.8 About GlobalData
5.9 Disclaimer
1.1 List of Tables
Table 1: Global Sales Forecast ($m) for Bipolar Disorder, 2014-2024
Table 2: Bipolar Disorder Market - Drivers and Barriers, 2014-2024
Table 3: Key Companies in the Bipolar Disorder Market in the 8MM, 2015
Table 4: Otsuka’s Bipolar Disorder Portfolio Assessment, 2015
Table 5: AstraZeneca’s Bipolar Disorder Portfolio Assessment, 2015
Table 6: Eli Lilly’s Bipolar Disorder Portfolio Assessment, 2015
Table 7: Allergan’s Bipolar Disorder Portfolio Assessment, 2015
Table 8: Dainippon Sumitomo’s Bipolar Disorder Portfolio Assessment, 2015
Table 9: Janssen Bipolar Disorder Portfolio Assessment, 2015
Table 10: Lundbeck Bipolar Disorder Portfolio Assessment, 2015
Table 11: Meiji Seika Bipolar Disorder Portfolio Assessment, 2015
Table 12: Key Launch Dates
Table 13: Key Patent Expiries
Table 14: High-Prescribing Physicians (Non-KOLs) Surveyed, By Country
1.2 List of Figures
Figure 1: Global Sales for Bipolar Disorder by Region, 2014-2024
Figure 2: Global Sales for Bipolar Disorder by Drug Class, 2014-2024
Figure 3: Global Sales of Products for Bipolar Disorder by Company, 2014-2024
Figure 4: Company Portfolio Gap Analysis in Bipolar Disorder, 2014-2024
Figure 5: Otsuka SWOT Analysis in Bipolar Disorder, 2014-2024
Figure 6: AstraZeneca SWOT Analysis in Bipolar Disorder, 2014-2024
Figure 7: Eli Lilly SWOT Analysis in Bipolar Disorder, 2014-2024
Figure 8: Allergan SWOT Analysis in Bipolar Disorder, 2014-2024
Figure 9: Dainippon Sumitomo SWOT Analysis in Bipolar Disorder, 2014-2024
Figure 10: Janssen SWOT Analysis in Bipolar Disorder, 2014-2024
Figure 11: Lundbeck SWOT Analysis in Bipolar Disorder, 2014-2024
Figure 12: Meiji Seika SWOT Analysis in Bipolar Disorder, 2014-2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report